Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cogent Biosciences Inc 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 USA

www.cogentbio.com Employees: 205 P: 617-945-5576

Sector:

Medical

Description:

Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 5,057,231
Enterprise Value, $K 5,069,661
Shares Outstanding, K 142,377
Annual Sales, $ 0 K
Annual Net Income, $ -255,860 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -80,930 K
EBIT, $ -307,600 K
EBITDA, $ -312,770 K
60-Month Beta 0.50
% of Insider Shareholders 7.29%
Float, K 131,998
% Float 92.71%
Short Interest 14,717
Short Float 10.34%
Short Volume Ratio 0.50

Growth:

1-Year Return 360.70%
3-Year Return 184.16%
5-Year Return 198.24%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 53.37%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.50 on 11/07/25
Next Earnings Date 02/24/26
Earnings Per Share ttm -1.64
EPS Growth vs. Prev Qtr 5.66%
EPS Growth vs. Prev Year 21.87%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/09/20

COGT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -236.36%
Return-on-Assets % -89.72%
Profit Margin % 0.00%
Debt/Equity 0.15
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 26.68
Book Value/Share 2.16
Interest Coverage -4.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar